Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.

Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37023883

about

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease Metabolomics in rheumatic diseases: desperately seeking biomarkers The interplay between inflammation and metabolism in rheumatoid arthritis From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine Mixing omics: combining genetics and metabolomics to study rheumatic diseases.Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment.A metabonomic study of adjuvant-induced arthritis in rats using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.Energy Metabolism Disorder as a Contributing Factor of Rheumatoid Arthritis: A Comparative Proteomic and Metabolomic Study.¹H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis.Association of urinary metabolites with radiographic progression of knee osteoarthritis in overweight and obese adults: an exploratory study Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathway Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 Response.Variations in the metabolome in response to disease activity of rheumatoid arthritis.Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-α Inhibitors in Rheumatoid Arthritis.Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.The impact of inflammation on metabolomic profiles in patients with arthritis.Metabolomics approach in allergic and rheumatic diseases.Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis.Lipid and Metabolic Changes in Rheumatoid Arthritis.Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management.Cytokines in rheumatoid arthritis - shaping the immunological landscape.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients.Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis.Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].The metabolomics of psoriatic disease.Metabolomics for rheumatic diseases: has the time come?Metabolomics in rheumatology.H NMR Metabolomics Identifies Underlying Inflammatory Pathology in Osteoarthritis and Rheumatoid Arthritis Synovial Joints Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis

P2860

Q26748481-FBE78679-7C9D-4FCA-94F2-239A7869F8F7 Q26765005-3C26388F-A011-49C2-9784-DD3C8F3BE8AF Q26785751-F94A5DDD-EECE-40BE-9D9E-382691CCD52C Q28067029-A96FE5A5-99F2-4300-B653-BCBD9279727A Q30238656-63473C05-DAEA-49A9-BEDD-1EF78F1BEDB0 Q34604608-572F3A5E-3798-459D-B05A-1D5D83836F01 Q34855603-83540A03-E2E2-4CE7-8247-22BADB969D6D Q35209586-8A7C04B2-5878-4A26-A79F-20A61E81864A Q35683210-45302835-41E2-4C13-A68D-1000A7838F49 Q35838512-5261CCCB-518C-4897-A307-82C0E86A21AC Q35969733-D383F56A-7683-4D39-A221-27A66DB0B400 Q36017886-B087987E-C049-489B-A63E-32A569ED35ED Q36093887-82DF8C20-A2DA-4701-B4B0-7F5A31D86E9A Q36109439-82F5BD49-1940-4855-A40C-A058D0B62CC2 Q36133726-2AF84023-34E1-43BF-A295-A6B9FCF5DCFA Q36166090-0598F4D2-583F-4E54-9F89-A499B5DF6F1F Q36231477-550CDF2F-B0C7-4356-8B94-3AF756FF191D Q37343272-ECF91FBA-D533-42C1-9A30-7A6EC42CAA3D Q38205414-38768266-4D5C-4C9B-B305-EC942FA412E8 Q38529234-55A68812-27D3-40B9-A461-FBA5867E95D1 Q38554197-84E7D8D3-5EAD-4E54-80C7-172ABDF7EF15 Q38619950-100F7017-AF1E-4EAA-A922-4280847CA7C3 Q38666239-D075880E-9B57-43C9-B39A-A8700E6D0A88 Q38797638-8775CCE8-B381-4D69-9724-D84F4063C4BF Q38850063-9E79D3B1-54AD-4D6B-8D95-0B84AC98492A Q39143968-012654CE-E2D3-40CF-B493-9C7496B71DE7 Q39367839-FD318F60-0418-4228-93CB-D7350F7DC65A Q40069331-3A0DB1A9-AC45-48A8-8DC0-6D08AF5DA35D Q42633541-2295578E-0DE0-49DA-88F0-52656BAE6D28 Q47141055-7DFC33CF-1B51-4F4E-A599-22D8ACCC0ED0 Q48198058-39E21CD7-04F9-4905-A00D-1EE165F97E00 Q52862596-911B5EB9-ECF6-417D-8A81-2C0ED54EE266 Q53103335-63D12055-082E-4D70-B625-AE7A88EAE65A Q54295445-55EC47D6-2446-49D5-AF57-070B9B3EDCF1 Q54767965-4E71B0FF-8828-4DA2-82B0-CC3B8CA15C29 Q57039021-F03B1220-C8DD-441A-8AB1-BABBE8DDFABA Q58801311-C7F32222-DF65-4B81-B88C-2407CC50DE6E

P2860

Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37023883

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@en

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@nl

type

label

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@en

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@nl

prefLabel

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@en

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@nl

P1433

Q37023883-88E75655-1B9D-4FB3-8388-1458E583137A

P1476

Q37023883-CBABC3AE-56F7-415D-8ECF-364162CC8B22

P2093

Q37023883-4860850D-F469-4CDB-B822-F89A485936A1

Q37023883-5C17DD73-F8EB-46FE-856C-E4EF4189BE80

Q37023883-61D1EEAC-A002-440E-8036-DB8E8CCFF3D0

Q37023883-AA4F330A-E42A-4F69-97F7-77D9DCCA6369

Q37023883-EDC52FED-31B6-4823-97BA-4309C123B710

Q37023883-FAE39329-7DB6-4EE2-82BF-5E7A3A623D89

P2860

Q37023883-030B822F-ADB4-410A-B0A0-386087FD77F9

Q37023883-0E551D9B-7AC9-4179-A8D5-05C03894987B

Q37023883-0E5F7C0D-CF12-466D-A4A6-F280AF9C7939

Q37023883-0EC7DD5F-3047-4A3B-93D2-B5A02FE0CDE5

Q37023883-1CDAFEDE-0F26-4627-992F-6B66E9C9783C

Q37023883-2D08120E-C53D-4E31-B259-EB0922C0EC41

Q37023883-32C8C7FE-5F08-447D-8900-EB579B5238FA

Q37023883-359A5FF0-49B7-4105-9077-F2668F5A865E

Q37023883-36BDE540-B680-4632-9F1D-70B731AE3FE2

Q37023883-3855EEAC-134A-4D8D-8EE7-A7AC1271A943

P304

Q37023883-3269498B-E95F-41DE-88B5-193647F131F8

P31

Q37023883-A7561C69-FF9F-48AC-BD65-3F2E76D38FFE

P356

Q37023883-A7437C3E-E858-4319-87EB-6A5BF89E9FC9

P433

Q37023883-14FB37D1-98A0-4E38-8865-663E45315B26

P478

Q37023883-6410CD37-2AE5-40A3-8D0E-2C8F51AFB9C5

P50

Q37023883-4A40E15A-E2E1-4D70-9195-D582E4D1CD0D

Q37023883-C3E4C6B1-3D4F-4F14-B974-B7DBE8770BE6

Q37023883-F7A05B9B-391B-47C6-8CF5-6B7D0D62741B

P577

Q37023883-E10E723A-5AB4-4543-AA1D-79A61AC30060

P5875

Q37023883-2D456AEC-9ABE-4F64-9996-0ECBA4AFF93C

P698

Q37023883-BDA5E38D-477D-4E22-AD18-E63788482561

P921

Q37023883-64221330-65C6-4148-802A-054A7ED9270D

P932

Q37023883-D2FB4C86-F360-47F4-8B7D-73273573C7FA

P356

P1433

Arthritis & Rheumatology

P1476

Metabolic profiling predicts r ...... nts with rheumatoid arthritis.

@en

P2093

Andrew Filer

http://www.w3.org/2001/XMLSchema#string

Benjamin A Fisher

http://www.w3.org/2001/XMLSchema#string

Christopher D Buckley

http://www.w3.org/2001/XMLSchema#string

Karim Raza

http://www.w3.org/2001/XMLSchema#string

Peter C Taylor

http://www.w3.org/2001/XMLSchema#string

Sabrina R Kapoor

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Improved methods for the acquisition and interpretation of NMR metabolomic data.

Microalbuminuria in patients with rheumatoid arthritis

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Etanercept (Enbrel): update on therapeutic use

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.

P304

1448-1456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.37921

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Stephen P Young

Martin A Fitzpatrick

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235787362

http://www.w3.org/2001/XMLSchema#string

P698

23460124

http://www.w3.org/2001/XMLSchema#string

P921

P932

3715109

http://www.w3.org/2001/XMLSchema#string